Bladder Cancer in Iran: An Epidemiological Review. 2020

Khadijeh Kalan Farmanfarma, and Neda Mahdavifar, and Hamid Salehiniya
Department of Epidemiology, Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.

OBJECTIVE Bladder cancer is the sixth most common cancer in Iran. Information about the epidemiological situation of the disease and its risk factors is necessary for conducting a planning program to reduce the disease. This study is conducted with the aim of evaluating the epidemiological features of bladder cancer in Iran. METHODS This is a systematic review of the published articles in both Persian and English in international and national journals during the years 2000-2019 with key words of Iran and bladder cancer. Articles were selected from the national information database (SID, Magiran) and international databases (PubMed, Scopus, and Web of Science). Articles related to the epidemiological aspects of the disease, including incidence, prevalence, mortality, and risk factors, were evaluated. RESULTS The incidence rate of bladder cancer was about 1.6-115; cumulative survival rate was 0.95, mortality rate was 0.5-0.84 and its prevalence in the Iranian population was between 4.10% and 12.8%. The risk of developing malignancy in major risk factor groups, including smoking and opium, was 6.2 (2.04-18.7), increases in protein and animal fat consumption were about 5- and 19-times higher than in the general population, respectively. In terms of occupational exposure, bus and heavy truck drivers were 11.3 (1.3-92.05) more at risk than others. CONCLUSIONS Regarding the increasing trend of this disease, changes in lifestyle to reduce risk factors can be effective in decreasing the incidence and mortality rate of this malignancy.

UI MeSH Term Description Entries

Related Publications

Khadijeh Kalan Farmanfarma, and Neda Mahdavifar, and Hamid Salehiniya
January 2007, The breast journal,
Khadijeh Kalan Farmanfarma, and Neda Mahdavifar, and Hamid Salehiniya
June 2020, Journal of gastrointestinal cancer,
Khadijeh Kalan Farmanfarma, and Neda Mahdavifar, and Hamid Salehiniya
January 2018, Journal of cancer research and therapeutics,
Khadijeh Kalan Farmanfarma, and Neda Mahdavifar, and Hamid Salehiniya
January 2008, Asian Pacific journal of cancer prevention : APJCP,
Khadijeh Kalan Farmanfarma, and Neda Mahdavifar, and Hamid Salehiniya
February 2022, Iranian journal of public health,
Khadijeh Kalan Farmanfarma, and Neda Mahdavifar, and Hamid Salehiniya
January 1963, Acta - Unio Internationalis Contra Cancrum,
Khadijeh Kalan Farmanfarma, and Neda Mahdavifar, and Hamid Salehiniya
January 1993, Urologiia i nefrologiia,
Khadijeh Kalan Farmanfarma, and Neda Mahdavifar, and Hamid Salehiniya
January 1985, International surgery,
Khadijeh Kalan Farmanfarma, and Neda Mahdavifar, and Hamid Salehiniya
January 2014, Iranian journal of pharmaceutical research : IJPR,
Khadijeh Kalan Farmanfarma, and Neda Mahdavifar, and Hamid Salehiniya
January 1996, Annali dell'Istituto superiore di sanita,
Copied contents to your clipboard!